Media Cover STSI Study Looking to Improve Parkinson's Diagnosis

Clinical trial combines DNA testing with wireless sensor to track participants

Scripps Translational Science Institute (STSI) has launched a clinical trial, the Molecular Autopsy Study. Researchers conducting the study hope that DNA sequencing can, for the first time, determine the root cause of sudden unexpected death in many families.

A number of media outlets have covered a newly launched clinical trial by the Scripps Translational Science Institute, which is using genetic testing and wireless sensors in an effort to improve the diagnosis of Parkinson’s disease.

Read the GenomeWeb article: STSI Launches Study to Improve Screening Accuracy for Parkinson’s Disease

Read the FierceMobile Healthcare article:Trial to Use Genetic Data, Wireless Sensor to Diagnose Parkinson’s Disease

Read the mHealth Intelligence article: mHealth Takes Aim at Parkinson’s

Read the Healthcare Informatics article: Scripps Launches Study Combining DNA Testing and Wireless Sensors to Improve Parkinson’s Diagnosis

Read the Healthcare IT article: New Scripps Study Combines DNA Testing, Sensors to Improve Parkinson’s Diagnosis

The Hospitals & Health Networks article, "3 Genomics Studies Underway at Scripps," is no longer available.

Media Contact

Keith Darce

Related tags: